Skip to content
Roche
-
Roche commits USD484M to boost South Korea’s biopharma ecosystem
The company formalized its commitment with South Korea’s Ministry of Health and Welfare to enhance the bio-healthcare industry by supporting international clinical trials and advancing research for innovative medicines.
-
Roche triples investment in North Carolina manufacturing plant to USD2B for obesity drug production
The plant is scheduled to begin operations by 2029 and will focus on producing cutting-edge treatments for metabolic conditions, particularly obesity medications.
-
MHRA approves Roche’s Itovebi for advanced breast cancer treatment
This oral formulation offers a more convenient delivery method compared to intravenous treatments.